Federal incentives fail to spur development of new drugs to treat rare diseases; alcohol-related deaths have risen steadily over the past several years; will CMS stop auto-enrolling low-income individuals in exchange health plans?
Despite greater availability of medicines for rare diseases that affect children, the development of new drugs to treat the over 7000 rare diseases that lack treatment has fallen behind novel indications of current therapies, according to a University of Michigan press release and study results from the journal Pediatrics. Drug manufacturers are often hesitant to produce pediatric rare disease drugs because of a lack of associated profit; however, the federal government offers tax incentives, testing grants, and a 7-year exclusivity period to spur their development. From 2010 to 2018, most pediatric orphan drug approvals were for existing drugs.
From 2000 to 2016, there was an almost 78% rise in deaths related to alcoholic liver disease in the United States, according to Forbes. Groups with the largest increases in alcohol-related deaths include American Indian and Alaska Native men and women, white women, and middle-aged individuals. Possible drivers behind this disturbing trend include increasing rates of alcoholism and heavy drinking at younger ages.
CMS is considering discontinuing its practice of automatically re-enrolling some low-income individuals in Affordable Care Act (ACA) health plans whose coverage is subsidized, reports Modern Healthcare. Detractors worry the move could lead to a rise in uninsured individuals, pointing out the need for more consumer education. In 2018, the Trump administration came close to eliminating the budget for plan outreach altogether, when it made cuts of 90%. A particular sticking point is the use of manufacturer drug coupons counting toward a consumer’s annual out-of-pocket spending limit: health insurers and employer groups support CMS' idea to stop this practice, while the Service Employees International Union claims doing so could make medications unaffordable to many.
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
2 Commerce Drive
Cranbury, NJ 08512